Colon Cancer Alliance Works To Break Down Barriers To Colon Cancer Screening

Examining the Role of Vitamin D in Colorectal Cancer Survival





In fact, it was reported that 1.23 million new cases of colorectal cancer were clinically diagnosed, with 608,000 death attributed to it in 2008 alone. Those at the greatest risk include men and women over the age of 60, African Americans and people of eastern European descent, patients with Crohns disease or ulcerative colitus, and those who have a family history of colon cancer, or who have a personal history of breast cancer. "The launch of our new Patient Support Navigator Haltia Serum Program is a dream come true," says Martha Raymond, Colon Cancer Alliance Patient Support and Outreach Director. "My goal of creating this program began several months ago when I visit this site realized the need for ongoing support and guidance for those who seek information from our organization. We are also working to tear down barriers to screening such as finances, fear, lack of knowledge, logistical

obstacles, etc. To learn more information about the Colon Cancer Alliance Patient Support Navigator Program, call the free Helpline at (877) 422-2030 Monday -Friday 9:00 a.m. - 5:00 p.m. Read more.. http://www.examiner.com/article/colon-cancer-alliance-works-to-break-down-barriers-to-colon-cancer-screening.









Cancer Res. 1987;47:21-25. Giuliano AR, Franceschi RT, Wood RJ. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys. 1991;285:261-269. Read more.. http://www.onclive.com/publications/obtn/2014/january-2014/examining-the-role-of-vitamin-d-in-colorectal-cancer-survival/2.












Doctors, older patients rethink cancer treatments





In some cases, it might make sense to scale back the standard recommended care for certain age groups, he said. In others, it is worthwhile to discuss the persons life expectancy and likelihood of a better quality of life without treatment, he said. In addition to pointing out when to hold back, research can confirm the value of chemotherapy and other treatments in patients once thought to be too old, Goldberg said. Sometimes it turns out that older patients can tolerate aggressive therapy and that chemo-lite isnt as good as a full dose, he said. Hurria said its important for research to focus on geriatric principles, such as the impact of treatment on maintaining independence and the way the cancer treatment interacts with the other medications patients take. Kuebler said he is hopeful that as more trials open, older patients will want to explore new options. Read more.. http://www.dispatch.com/content/stories/local/2014/01/26/your-health/1-doctors-older-patients-rethink-cancer-treatments.html.